Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
Wai Yuen Tong Medicine Holdings Ltd
Cash from Financing Activities
Wai Yuen Tong Medicine Holdings Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
W
|
Wai Yuen Tong Medicine Holdings Ltd
HKEX:897
|
Cash from Financing Activities
-HK$443.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
U
|
United Laboratories International Holdings Ltd
HKEX:3933
|
Cash from Financing Activities
-¥1B
|
CAGR 3-Years
19%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
S
|
Sino Biopharmaceutical Ltd
HKEX:1177
|
Cash from Financing Activities
-¥5.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-30%
|
C
|
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
|
Cash from Financing Activities
-¥882.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
C
|
China Resources Pharmaceutical Group Ltd
HKEX:3320
|
Cash from Financing Activities
-HK$6.2B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
HUTCHMED (China) Ltd
LSE:HCM
|
Cash from Financing Activities
$48.7m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
14%
|
See Also
What is Wai Yuen Tong Medicine Holdings Ltd's Cash from Financing Activities?
Cash from Financing Activities
-443.7m
HKD
Based on the financial report for Sep 30, 2023, Wai Yuen Tong Medicine Holdings Ltd's Cash from Financing Activities amounts to -443.7m HKD.
What is Wai Yuen Tong Medicine Holdings Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-26%
Over the last year, the Cash from Financing Activities growth was -148%. The average annual Cash from Financing Activities growth rates for Wai Yuen Tong Medicine Holdings Ltd have been -26% over the past three years .